VLA Comment: I would say 99% of the population are like sheep…have no idea or even common sense about how this vector insects became so virulent and suddenly ubiquitous. And how their ubiquitous presence coincides with multimillion companies spending millions on fake beef in tandem with a concerted effort by Climate Change apologists to get rid of Cows. Like in this video…where a Canadian says he practically lived in the forest behind his house and rarely…rarely saw a tick.
I lived in Long Island as a child and I NEVER saw a tick. I had an experience, like the gal in the video….I saw a tick jump from the wall of my house onto me at a length of about 8″. The other day I was at the pool on the deck and felt a something feathery coming from the sky. I got up and looked at my bathrobe. There were about 30 ticks caught immobile in the terry cloth material of my robe.
Below: Moose heavily infested with winter ticks (Dermacentor albipictus), often harboring 10,000 to over 100,000 parasites.
Wake up and point to the Cause. By not waking up to the reality of WAR on every level you will get sick and die. Focus on Fort Detrick/government Bioweapon centers. Since they created the plague…perhaps they have the wherewithal to undo what they have done. Probably not…during the 7 years Tribulation…but it is a shot.
Nicolas Hulscher, MPH
A newly published peer-reviewed study in Gut Microbes has uncovered a previously unknown cancer-fighting bacterium isolated from amphibian and reptile gut microbiomes—delivering results that exceeded modern oncology treatments.
In an immunocompetent mouse model of colorectal cancer, a single intravenous dose of Ewingella americana led to complete tumor elimination in 100% of treated animals, with no recurrence upon re-exposure to cancer cells—suggesting durable, long-term immune protection.
 |
Even more striking, the bacterium outperformed both chemotherapy (doxorubicin, “red devil”) and immune checkpoint blockade (anti–PD-L1)—two pillars of modern cancer therapy.
What makes this discovery particularly compelling is the mechanism. E. americana is not a passive drug—it is a living, tumor-targeting organism. As a facultative anaerobe, it preferentially accumulates within the hypoxic tumor microenvironment, where it rapidly proliferates and exerts direct cytotoxic effects while simultaneously activating a broad immune response. Within hours, tumors become infiltrated with T cells, B cells, and neutrophils, accompanied by surges in key inflammatory cytokines like TNF-α and IFN-γ.
Investigators observed approximately a 3,000-fold increase in bacterial load within tumors within 24 hours, indicating highly efficient tumor homing and intratumoral expansion. This dual-action approach—direct tumor destruction combined with immune activation—distinguishes it fundamentally from conventional therapies, which typically rely on a single mechanism of action.
Equally notable is the safety profile observed in this preclinical model. Despite intravenous administration of live bacteria, treated animals showed no significant weight loss, no detectable organ toxicity, and no abnormalities in hematologic or biochemical parameters. The organism was rapidly cleared from circulation within 24 hours, while remaining selectively localized within tumor tissue—an unusual and highly favorable pharmacokinetic pattern.
Importantly, this was not a genetically engineered construct. E. americana is a naturally occurring bacterium, suggesting that vast, largely unexplored microbial ecosystems—particularly those of non-human species—may harbor powerful therapeutic agents.
While these results remain preclinical and require validation in human trials, the signal is difficult to ignore. A single-dose intervention achieving complete tumor eradication, durable immune memory, and superiority over established therapies represents one of the most striking outcomes reported in recent cancer research.
Lyme Disease: The most common vector-borne illness in the country—more prevalent than West Nile, more pervasive than Rocky Mountain spotted fever, and far more mysterious than any public health official cares to admit.
VLA Comment: Best I have read so far. Never mentioned, not even on Wikipedia…always given kudos for discovery the bacterium Lyme Disease, that Dr. Burgdorfer was a bioweapons specialist at Fort Detrick.
Excerpt:And who was one of the key scientists working on tick-borne diseases during this period? None other than Dr. Willy Burgdorfer. You might know him as the man who discovered the bacterium Borrelia burgdorferi. You know, the bacteria that allegedly cause Lyme disease. Burgdorfer was a bioweapons specialist at Fort Detrick. His entire career was steeped in the art of turning insects into instruments of war. He didn’t just study ticks; he studied how to make them weapons.
